Polymyositis Panel
Also known as: POLY MYO
Use
This antibody panel is useful for evaluation of patients with progressive proximal muscle weakness and antisynthetase syndrome. Detection of myositis‑specific and associated antibodies may help establish diagnosis, support prognosis, and guide treatment decisions in inflammatory myopathies such as polymyositis, antisynthetase syndrome, necrotizing autoimmune myopathy, and overlap syndromes. Use of a targeted panel matching the clinical phenotype is recommended.
Special Instructions
Change effective as of 01/21/25: refer to test code 3018868 in the January Hotline for updated panel information.
Limitations
Results are not diagnostic in isolation and should be interpreted within the full clinical context. Negative results do not rule out inflammatory myopathy or overlap syndromes.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Result Turnaround Time
7-18 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
